Pioneer Trust Bank’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$323K Sell
5,610
-320
-5% -$18.4K 0.07% 75
2026
Q1
$360K Buy
+5,930
New +$346K 0.09% 69
2021
Q2
Sell
-4,253
Closed -$268K 72
2021
Q1
$268K Sell
4,253
-1
-0% -$62 0.08% 65
2020
Q4
$264K Hold
4,254
0.08% 65
2020
Q3
$257K Hold
4,254
0.09% 62
2020
Q2
$250K Buy
4,254
+400
+10% +$23.9K 0.1% 62
2020
Q1
$215K Buy
+3,854
New +$236K 0.1% 63
2018
Q3
Sell
-3,649
Closed -$202K 72
2018
Q2
$202K Buy
+3,649
New +$197K 0.1% 76

Other funds holding BMY

Pioneer Trust Bank's BMY Position: Q2 2026 in Review

Pioneer Trust Bank reduced its Bristol-Myers Squibb (BMY) stake by 5.4% in Q2 2026, selling an estimated $18.4K and leaving 5,610 shares worth $323K. The position accounts for 0.07% of the portfolio, ranked #75.

Pioneer Trust Bank first reported a position in BMY in Q2 2018 and has held it in 8 quarters since. The position peaked at $360K in Q1 2026. 2,502 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Pioneer Trust Bank held 5,610 shares of Bristol-Myers Squibb worth $323K as of Q2 2026.
  • Pioneer Trust Bank sold 320 Bristol-Myers Squibb shares in Q2 2026, an estimated $18.4K.
  • Bristol-Myers Squibb made up 0.07% of Pioneer Trust Bank's portfolio in Q2 2026, its #75 holding.
  • Pioneer Trust Bank first reported a position in Bristol-Myers Squibb in Q2 2018 and has held it in 8 quarters since.
  • Pioneer Trust Bank's Bristol-Myers Squibb position peaked at $360K in Q1 2026.
  • 2,502 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Pioneer Trust Bank's 13F filing for Q2 2026, filed 23 Jul 2026.